(Q45862997)

17 December 2017

title

Proinflammatory progranulin antibodies in inflammatory bowel diseases (English)

1 reference

17 December 2017

1 reference

12

1 reference

17 December 2017

Michael Pfreundschuh

13

object named as

Michael Pfreundschuh

0 references

author name string

Lorenz Thurner

1

1 reference

17 December 2017

Elisabeth Stöger

2

1 reference

17 December 2017

Natalie Fadle

3

1 reference

17 December 2017

Philipp Klemm

4

1 reference

17 December 2017

Evi Regitz

5

1 reference

17 December 2017

Maria Kemele

6

1 reference

17 December 2017

Birgit Bette

7

1 reference

17 December 2017

Gerhard Held

8

1 reference

17 December 2017

Marc Dauer

9

1 reference

17 December 2017

Frank Lammert

10

1 reference

17 December 2017

Klaus-Dieter Preuss

11

1 reference

17 December 2017

publication date

4 March 2014

1 reference

17 December 2017

Digestive Diseases and Sciences

published in

1 reference

17 December 2017

volume

59

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

1733-1742

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s10620-014-3089-3

exact match

0 references

cites work

Progranulin antibodies in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Structure, function, and mechanism of progranulin; the brain and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Progranulin does not bind tumor necrosis factor (TNF) receptors and is not a direct regulator of TNF-dependent signaling or bioactivity in immune or neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Adult-onset immunodeficiency in Thailand and Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Cellular localization of gene expression for progranulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Exacerbation of ulcerative colitis after rituximab salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Surveillance B lymphocytes and mucosal immunoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Bacterial flagellin is a dominant antigen in Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Suppressor activity among CD4+,CD25++ T cells is discriminated by membrane-bound tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3089-3

Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease

21 January 2018

1 reference

12 December 2020

Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin

1 reference

12 December 2020

Towards the next generation of anti-TNF drugs

1 reference

12 December 2020

Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease

1 reference

12 December 2020

pANCA represents a cross-reactivity to enteric bacterial antigens

1 reference

12 December 2020

Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer

1 reference

12 December 2020

10.1007/S10620-014-3089-3

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017